ACHIEVE P1 - HTN
实现 P1 - HTN
基本信息
- 批准号:10437396
- 负责人:
- 金额:$ 53.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccountingAddressAdoptionAdultAdvocateAlgorithmsAmericanAtherosclerosisBlood PressureCOVID-19Cardiovascular DiseasesCaringCenters for Disease Control and Prevention (U.S.)Chronic Kidney FailureCitiesCommunitiesCommunity Health AidesCoupledDataDisadvantagedDiseaseEarly treatmentEducationEffectivenessEmploymentEnvironmentEventEvidence based practiceFaceFailureFamiliarityGoalsGreat Lakes RegionGuidelinesHealthHealth Services AccessibilityHealth educationHeartHeart DiseasesHeart failureHigh PrevalenceHomeHybridsHypertensionImprove AccessIndividualInterventionLengthLifeLife StyleLinkMaintenanceMedicalMethodsMobile Health UnitsModelingMorbidity - disease rateOutcomePatientsPharmaceutical PreparationsPharmacistsPhasePractical, Robust Implementation and Sustainability ModelPreventionProcessQuasi-experimentResearchResourcesRiskRisk FactorsRoleStructureTarget PopulationsTestingTimeUnited StatesUrban CommunityVaccinatedblack patientblood pressure reductionblood pressure regulationburden of illnesscardiometabolismcardiovascular disorder riskcardiovascular risk factorcare deliverycare systemscollaborative carecoronavirus diseasecost effectivenessevidence basehealth care availabilityhealth disparityhealth equityhealth inequalitieshealth literacyhypertension controlimprovedinnovationmHealthmortalitynoveloutreachpreventprimary outcomeprogramssocial determinantssocial vulnerabilitysuccess
项目摘要
PROJECT SUMMARY
Hypertension is the leading risk factor for global morbidity and mortality. Even mild elevations in blood pressure
(BP) are harmful whereby individuals with stage 1 hypertension are at double cardiovascular risk. Black adults
suffer from a higher prevalence, worse control rates, and more frequent adverse health effects from high BP.
They are also at heightened risk for an earlier accelerated progression from mild to more severe hypertension.
Little progress has been made in mitigating health inequities related to high BP. Predominantly Black cities
such as Detroit disproportionately suffer from nearly twice the national average mortality rate due to heart
disease. Mounting evidence shows that pervasive negative social determinants of heath (SDoH) are major
drivers of these inequities and represent a critical barrier to achieving BP control in Black hypertensives. Core
issues include poor access to healthcare and a burdensome system for care linkage especially in under-
resourced settings, low health education and literacy, and structural inadequacies in care delivery including a
failure to address the spectrum of life circumstances that elevate BP and hinder the adoption of salutary
lifestyle changes. In PROJECT 1 of the ACHIEVE GREATER research center, we propose an innovative
approach to identify and control hypertension at its earliest stages in undiagnosed Black adults, potentially
yielding an enormous benefit towards lifetime health equity. Using a hybrid type I effectiveness-implementation
and quasi-experimental design, we will leverage our novel mobile health unite (MHU) platform to implement a
program that links low risk Black adults with stage 1 hypertension to collaborative care delivered by non-
physicians, community health workers (CHWs) and pharmacists, consisting of a personalized, adaptable
approach to lifestyle and life circumstance (PAL2) intervention for 12-months. Core features of PAL2 include the
ability to choose from a menu of readily available interventions that address individual negative SDoH,
culturally sensitive health and lifestyle education, and adaptability over time according to its acceptance,
effectiveness (home BP), and evolving patient needs. If BP remains ≥130/80 mm Hg after 6 months, a
pharmacist-directed medical treatment algorithm will be added to achieve timely BP control. Program benefits
including BP-lowering will be assessed during the implementation (12-months) and maintenance phases (year
2) after linkage to medical care. We aim to show the effectiveness of project 1 to lower home BP after 12
months in 500 Black patients with mild stage 1 hypertension living in disadvantaged communities in Detroit and
to reach the target population. We also aim to evaluate the fidelity and outcomes of project 1 and examine its
cost effectiveness. Improving care access by strategic MHU outreach, coupled with enhanced collaborative
care, can effectively remove barriers, mitigate negative SDoH and improve BP control in Black adults with
hypertension. PROJECT 1 of the ACHIEVE GREATER center represents a novel and scalable model to
advance health equity in urban Black communities across the United States that continue to face disparities.
项目概要
高血压是全球发病率和死亡率的主要危险因素,即使血压轻微升高。
(BP) 是有害的,因此患有 1 期高血压的黑人成人面临双倍的心血管风险。
高血压的患病率较高,控制率较差,并且更频繁地对健康造成不良影响。
他们还面临胃肠道风险,容易从轻度高血压加速进展为更严重的高血压。
在缓解以黑人为主的高血压城市相关的健康不平等方面进展甚微。
例如底特律,心脏病死亡率几乎是全国平均死亡率的两倍
越来越多的证据表明,普遍存在的健康负面社会决定因素 (SDoH) 是主要因素。
这些不平等的驱动因素,也是黑人高血压患者实现血压控制的关键障碍。
问题包括获得医疗保健的机会较差以及护理联系系统繁重,特别是在欠发达地区
资源环境、健康教育和识字率低以及护理服务的结构性不足,包括
未能解决导致血压升高并阻碍采用有益健康的生活环境
在 ACHIEVE GREATER 研究中心的项目 1 中,我们提出了一种创新的生活方式。
在未确诊的黑人成人中尽早识别和控制高血压的方法,可能
使用混合型 I 型有效性实施可为终生健康公平带来巨大益处。
和准实验设计,我们将利用我们新颖的移动健康联合(MHU)平台来实现
该计划将患有 1 期高血压的低风险黑人成人与非
医生、社区卫生工作者 (CHW) 和药剂师,由个性化、适应性强的人员组成
为期 12 个月的生活方式和生活环境 (PAL2) 干预方法 PAL2 的核心特征包括:
能够从一系列现成的干预措施中进行选择,以解决个人的负面 SDoH 问题,
具有文化敏感性的健康和生活方式教育,以及根据其接受程度随时间推移的适应性,
有效性(家庭血压)和不断变化的患者需求 如果 6 个月后血压仍然≥130/80 mm Hg,则
将添加药剂师指导的医疗算法,以实现及时的血压控制。
包括降压将在实施阶段(12 个月)和维护阶段(一年)进行评估
2) 与医疗保健挂钩后 我们的目标是展示项目 1 在 12 点后降低家庭血压的有效性。
生活在底特律贫困社区的 500 名轻度 1 期高血压黑人患者的几个月
我们还旨在评估项目 1 的保真度和结果并检查其。
通过战略性 MHU 外展以及加强协作来改善医疗服务的可及性。
护理,可以有效消除障碍,减轻负面 SDoH 并改善黑人成人的血压控制
ACHIEVE GREATER 中心的项目 1 代表了一种新颖且可扩展的模型。
美国各地城市黑人社区的健康公平性不断进步,但仍然面临着不平等。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Daniel Brook其他文献
Robert Daniel Brook的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Daniel Brook', 18)}}的其他基金
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
减少颗粒物对老年人心血管健康的影响
- 批准号:
10011861 - 财政年份:2014
- 资助金额:
$ 53.78万 - 项目类别:
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
减少颗粒物对老年人心血管健康的影响
- 批准号:
10427306 - 财政年份:2014
- 资助金额:
$ 53.78万 - 项目类别:
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
减少颗粒物对老年人心血管健康的影响
- 批准号:
10207776 - 财政年份:2014
- 资助金额:
$ 53.78万 - 项目类别:
ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
ASPIRE:空气污染:减少接触的个性化干预策略
- 批准号:
9754146 - 财政年份:2011
- 资助金额:
$ 53.78万 - 项目类别:
COUNTERACT Supplement--ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
COUNTERACT 补充--ASPIRE:空气污染:减少接触的个性化干预策略
- 批准号:
10218398 - 财政年份:2011
- 资助金额:
$ 53.78万 - 项目类别:
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
内皮功能之间的心血管联系
- 批准号:
7603730 - 财政年份:2007
- 资助金额:
$ 53.78万 - 项目类别:
VASCULAR TISSUE ANGIOTENSINII & ENDOTHELIAL DYSFUNCTION IN UNCOMPLICATED OBESITY
血管组织血管紧张素II
- 批准号:
7376511 - 财政年份:2006
- 资助金额:
$ 53.78万 - 项目类别:
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
内皮功能之间的心血管联系
- 批准号:
7376546 - 财政年份:2006
- 资助金额:
$ 53.78万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Multi-level interventions for addressing tobacco cessation and SDOH in Community Health Centers (CHCs)
解决社区卫生中心 (CHC) 戒烟和 SDOH 问题的多层次干预措施
- 批准号:
10661440 - 财政年份:2023
- 资助金额:
$ 53.78万 - 项目类别:
Person-centered quality measurement and management in a system for addictions treatment in New York State
纽约州成瘾治疗系统中以人为本的质量测量和管理
- 批准号:
10772463 - 财政年份:2023
- 资助金额:
$ 53.78万 - 项目类别:
Effects of Medicaid IMD SUD waiver on access to addiction treatment
医疗补助 IMD SUD 豁免对获得成瘾治疗的影响
- 批准号:
10726979 - 财政年份:2023
- 资助金额:
$ 53.78万 - 项目类别:
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 53.78万 - 项目类别:
Strategies to improve Utilization of Post-overdose Evidence-based Risk mitigation among Non-fatal Overdoses in VA (SUPER NOVA)
提高药物过量后利用率的策略 基于证据的 VA 非致命药物过量风险缓解策略 (SUPER NOVA)
- 批准号:
10425936 - 财政年份:2023
- 资助金额:
$ 53.78万 - 项目类别: